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A precise assessment of the drug-resistant epileptic pediatric pop-
ulation for surgical candidacy is often challenging, and to date there
are no evidence-based guidelines for presurgical identification of
the epileptogenic zone. To evaluate the usefulness of radionuclide
imaging techniques for presurgical evaluation of epileptic pediatric
patients, we compared the results of video-electroencephalography
(EEG), brain MR imaging, interictal SPECT, ictal SPECT, subtraction
ictal SPECT coregistered to MR imaging (SISCOM), and interictal
PET with 18F-FDG. Methods: Fifty-four children with drug-resistant
epilepsy who had undergone video-EEG monitoring, brain MR im-
aging, interictal and ictal brain perfusion SPECT, SISCOM, and 18F-
FDG PET were included in this study. All abnormal findings revealed
by these neuroimaging techniques were compared with the pre-
sumed location of the epileptogenic zone (PEZ) as determined by
video-EEG and clinical data. The proportion of localizing studies for
each technique was statistically compared. In the 18 patients who
underwent resective brain surgery, neuroimaging results were com-
pared with histopathology results and surgical outcome. Results:
SISCOM and 18F-FDG PET concordance with the PEZ was significantly
higher than MR imaging (P , 0.05). MR imaging showed localizing
results in 21 of 54 cases (39%), SISCOM in 36 of 54 cases (67%),
and 18F-FDG PET in 31 of 54 cases (57%). If we consider SISCOM
and 18F-FDG PET results together, nuclear medicine imaging tech-
niques showed coinciding video-EEG results in 76% of patients
(41/54). In those cases in which MR imaging failed to identify any
epileptogenic lesion (61% [33/54]), SISCOM or 18F-FDG PET find-
ings matched PEZ in 67% (22/33) of cases. Conclusion: SISCOM
and 18F-FDG PET provide complementary presurgical information
that matched video-EEG results and clinical data in three fourths
of our sample. SISCOM was particularly useful in those cases in
which MR imaging findings were abnormal but no epileptogenic
lesion was identified. Radionuclide imaging techniques are both
useful and reliable, extending the possibility of surgical treatment
to patients who may have been discouraged without a nuclear med-
icine approach.
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Children with drug-resistant epilepsy usually respond more read-
ily to surgery than adult patients mainly due to the greater plas-
ticity of the immature brain (1). In the presurgical evaluation of
these patients, the limits of the epileptogenic brain area, referred
to as the epileptogenic zone (EZ), need to be precisely determined.
EZ is defined in theory as “the minimum amount of cortex that
must be resected to produce seizure freedom” (2). However, in
practice, the EZ is a theoretic concept; only if seizure freedom is
achieved after surgery can it be concluded that the EZ must have
been included in the resected cortex (3).
Although an intracranial electroencephalogram (iEEG) with
correctly placed electrodes remains the gold standard procedure
in the delimitation of a focal EZ, the invasiveness of this tech-
nique limits its use to only those patients with ambiguous findings
(4).
Patients usually begin their assessment with a video-electroen-
cephalogram (EEG) and preidentification of the presumed epilep-
togenic brain lesion by MR imaging. Nonetheless, in some cases
MR imaging shows multifocal structural abnormalities or fails to show
any lesion at all (5) despite localizing features on seizure semiology
and EEG. In the pediatric population, this situation is often due to
a poor differentiation between gray and white matter and a higher
frequency of cortical dysplasia (6), a type of lesion that often shows
negative on MR imaging scans (7).
Complex drug-resistant epilepsy cases, and the pediatric pop-
ulation in particular, can benefit from the use of nuclear medicine
imaging techniques such as interictal and ictal brain perfusion
SPECT, subtraction ictal SPECT coregistered to MR imaging
(SISCOM), and interictal PET with 18F-FDG (8,9). Radionuclide
imaging techniques can offer a complementary function in the
localization of the epileptogenic focus (5,10–15). However, most
studies refer to an adult population, analyzing the contribution of
these techniques independently. Few have directly contrasted mul-
tiple neuroimaging methods in children (8,16–19).
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The aim of this work was to evaluate the usefulness of SISCOM
and 18F-FDG PET in the process of presurgical EZ identification
in drug-resistant epileptic pediatric patients by comparing these
techniques with conventional diagnostic procedures.
MATERIALS AND METHODS
Patients
Patient evaluation was performed as part of the clinical work-up
judged necessary to optimally localize the EZ using clinical and neu-
ropsychologic examination, EEG surveillance, and anatomic and func-
tional neuroimaging studies. SISCOM or 18F-FDG PET studies are
requested after MR imaging in patients who are candidates for surgery,
especially in cases of unclear or diffuse video-EEG results; normal MR
imaging, multiple MR imaging lesions, or MR imaging findings dis-
cordant to video-EEG; for the evaluation of potential secondary epi-
leptic foci; for iEEG placement guidance; to better define the limits of
the brain area to be resected; and for evaluating the functional in-
tegrity of the rest of the brain (9).
We retrospectively reviewed 122 children with medically intracta-
ble epilepsy who underwent video-EEG and MR imaging evaluation for
presurgical assessment between 2006 and 2012. The inclusion criteria
for this analysis were that all patients had undergone video-EEG mon-
itoring, brain MR imaging, SISCOM, and 18F-FDG PET studies. Ra-
dionuclide imaging was not performed in 33 cases because it was judged
not necessary in cases of multifocal epilepsy, nonepileptic paroxysmal
events, and MR imaging lesions in eloquent areas that excluded sur-
gical treatment or when MR imaging showed a structural lesion that
was clearly concordant with video-EEG. In 25 occasions, ictal SPECT
was requested but not achievable because of the short duration of or
lack of seizures on the injection day. In 10 patients, 18F-FDG PETwas
not requested in view of MR imaging and SISCOM findings. Finally,
54 children (29 male, 25 female) with an age range of 1–22 y (mean, 8
y) were included for study. Informed written consent was obtained
from all patients or their parents or legal guardians, and all procedures
were approved by the hospital Ethics Committee.
Scalp-EEG Recording and Video-EEG Monitoring
Video-EEG monitoring was performed in the epilepsy unit for 5 d,
and antiepileptic drugs were reduced when necessary to facilitate seizure
occurrence. Video-EEG monitoring was performed using Deltamed
equipment (Natus Medical Inc.) and was interpreted by an epileptol-
ogist who had experience with pediatric EEG.
MR Imaging
MR imaging was performed using a 1.5-T unit (Signa Exite; GE
Healthcare) with a specific epilepsy protocol. Sedation was used in selected
cases. All MR imaging studies were interpreted visually by an expert
neuroradiologist.
SPECT and SISCOM
Ictal SPECT was performed as part of patient admission for video-
EEG monitoring at the epilepsy unit of our center. Seizure onset was
defined as the time of earliest indication of auras or the beginning
of the rhythmic ictal discharges detected by video-EEG continuous
monitoring. The radiotracer was administered intravenously at seizure
onset by an experienced nurse trained to inject radioactive material
and waiting in the EEG technician’s room on the day of the ictal study.
Interictal SPECT was performed within the following week. Ictal and
interictal SPECT studies were performed with 99mTc-ethyl cysteinate
dimer or 99mTc-hexamethylpropyleneamine-oxime. SPECT studies were
acquired within 2 h of radioisotope injection and following the same
protocol using a dual-head SPECT imaging system (Infinia Hawkeye 4;
GE Healthcare) with a specific epilepsy protocol
Abnormal findings were defined purely on visual assessment as a
hypoperfused area in interictal SPECT and a hyperperfused area in
ictal SPECT. SISCOM images were obtained by a subtraction of the
interictal study from the ictal SPECT and coregistered to an MR
image. Abnormal findings were defined by the visual evaluation of
brain areas greater than 2 SDs above mean activity of the subtraction
image considering all voxels.
18F-FDG PET Imaging
18F-FDG PET images were acquired in 3-dimensional mode using
PET/CT equipment (Biograph; Siemens) with a specific epilepsy pro-
tocol. Sedation was used in selected cases and a portable EEG was
used to detect possible ictal discharges during the study. 18F-FDG PET
studies were registered with MR imaging using registration algorithms
in FocusDET, with a multiresolution rigid registration scheme. Fusion
images were interpreted exclusively by visual evaluation with a trans-
parency of 18F-FDG PET over the MR images that could be adjusted
to any degree of fusion: from displaying only 18F-FDG PET images to
only MR images. Abnormal findings were defined as hypometabolic
brain areas shown in 18F-FDG PET.
Dose administration, software description, and acquisition param-
eters for video-EEG, MR imaging, SPECT, SISCOM, and 18F-FDG PET
are set out in the supplemental data (available at http://jnm.snmjournals.org).
Image Interpretation and Statistical Analysis
All neuroimaging modalities were prospectively evaluated by special-
ists masked from clinical data and other study results. We retrospec-
tively reviewed the neuroimaging results of all 54 patients included in
this study.
SPECT, SISCOM, and 18F-FDG PET image interpretations were
performed conjunctly by 2 nuclear medicine physicians. The location
of the presumed epileptogenic zone (PEZ) was determined by consen-
sus during patient management meetings in the epilepsy unit, taking
into account video-EEG monitoring data as well as clinical and neuro-
psychologic data. The following concepts were used to classify neuro-
imaging results. The classification localizing study was used when the
location of the abnormal finding revealed by any of the neuroimaging
techniques was concordant with the brain location of PEZ. When the
abnormal finding was localized in the same hemisphere but not ex-
actly concordant with the brain location of PEZ, the classification was
lateralizing study. The not-localizing-study category was used for cases
in which abnormal findings were visualized but could not be corre-
lated to PEZ (malacic changes related to ischemic or traumatic lesions,
multiple tubers, hippocampus sclerosis, or hemispheric atrophy). When
the location of the abnormal findings was discordant with the brain
location of PEZ, the study was considered discordant, and in the
absence of abnormal findings, the study was considered normal.
The proportion of localizing studies found by MR imaging, SISCOM,
and 18F-FDG PET was reported with its 95% confidence interval (CI).
The proportions obtained using each technique were compared by
means of the McNemar test, with a P value of less than 0.05 considered
significant. A k statistic of concordance was also calculated where
relevant. Statistical procedures were performed using SPSS (version
17.0; SPSS Inc.).
Surgical Treatment and Follow-up
On the basis of the standard evaluation protocol of the epilepsy unit,
taking into consideration all clinical, electrophysiologic, and neuro-
imaging data, patient surgical candidacy was settled. Lobar or multi-
lobar selective cortical resection was performed by neurosurgeons from
the epilepsy unit. In selected cases, iEEG was used to better delimit the
focal epileptogenic region. All resected brain tissue was sent to the
anatomopathology department for histopathologic analysis.
The postoperative seizure outcome 6 and 12 mo after final surgery
was analyzed. Surgical outcome was classified according to Engel’s
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classification scheme: Engel class I (completely seizure-free, auras
only, or atypical early postoperative seizures only), Engel class II ($90%
seizure reduction or nocturnal seizures only), Engel class III ($50%
seizure reduction), and Engel class IV (,50% seizure reduction).
Patients who were operated on were divided into 2 subgroups: favor-
able outcome (Engel class I and II) and nonfavorable outcome (Engel
class III and IV).
RESULTS
Seizure Focus Localization
When clinical data and video-EEG were combined, the epilepsy
unit at our center was able to define the PEZ in 47 of 54 patients
(87%). In the remaining 7 patients, video-EEG showed lateralizing
results in 5, 1 case of multifocal activity, and in the remaining case
video-EEG failed to record seizures.
MR imaging findings were abnormal in 28 of 54 (52%) patients:
in 21 of 54 cases (39%; 95% CI, 27%–52%), MR imaging showed
a lesion concordant with PEZ (localizing study), and in 6 of 54
(11%) studies, it was not possible to correlate the findings with
PEZ (not-localizing study). This latter group consisted of 2 cases
of multiple cortical tubers, 2 large ischemic lesions, and 2 cases of
encephalomalacia. In the remaining case (patient 34), MR imaging
showed a cavernous malformation that did not match video-EEG
results and was classified as discordant. No abnormalities were
found in 26 of 54 (48%) MR imaging studies, and these cases
were considered normal.
Interictal SPECT findings were abnormal in 26 of 54 (48%)
patients: 17 of 54 (31%) of these cases were classified as localizing
study, and the remaining 9 of 54 abnormal (17%) studies com-
prised 4 lateralizing-study cases, 1 discordant-study case, and 4
not-localizing-study cases. Interictal SPECT studies were classi-
fied as normal in 28 of 54 (52%) cases.
Ictal SPECT study findings were abnormal in 35 of 54 (65%)
patients: 27 of 54 (50%) were classified as localizing study, and there
were 4 lateralizing-study, 2 discordant-study, and 2 not-localizing-
study cases. Ictal SPECT studies were classified as normal in 19 of
54 (35%) cases. The average duration of seizures was 56 s (range,
2–234 s), and the average time from seizure onset to radiotracer
injection was 17 s (range, 2–69 s).
SISCOM results were abnormal in 41 of 54 (76%) patients: 36
of 54 (67%; 95% CI, 53%–78%) cases were classified as local-
izing study, with 2 of 54 (4%) lateralizing-study cases and 3 of 54
(6%) discordant-study cases. SISCOM studies were classified as
normal in 13 of 54 (24%) cases.
18F-FDG PET results were abnormal in 41 of 54 (76%) patients:
31 of 54 (57%; 95% CI, 44%–70%) cases were classified as lo-
calizing study, and there were 2 lateralizing-study, 2 discordant-
study, and 6 not-localizing-study cases. 18F-FDG PET studies
were classified as normal in 13 of 54 (24%) cases.
MR Imaging, SISCOM, and 18F-FDG PET Comparison
A significant difference was found when comparing the proportion
of SISCOM localizing study with MR imaging (67% vs. 39%, P5
0.001) and ictal SPECT (67% vs. 50%, P 5 0.004). Also the pro-
portion of 18F-FDG PET localizing study was significantly higher
than MR imaging (57% vs. 39%, P 5 0.03). If we group SISCOM
and 18F-FDG PET results together, nuclear medicine imaging tech-
niques showed localizing study in 41 of 54 (76%) of cases (Fig. 1).
MR imaging failed to show an epileptogenic lesion that matched
PEZ (normal1 not-localizing1 discordant study) in 33 of 54 (61%)
patients (Fig. 2). Within this group, SISCOM or 18F-FDG PET
successfully presented localizing-study results on 22 of 33 (67%)
occasions (in 8 cases exclusively by SISCOM [patients 8, 13, 14,
25, 27, 48, 52, and 54], in 3 cases exclusively by 18F-FDG PET
[patients 11, 15, and 21], and in 11 cases both). From all 6 of 54
(11%) not-localizing-study MR imaging cases, positive SISCOM
findings matched the PEZ in 5 of 6 (83%) of the patients and were
therefore classified as localizing study. 18F-FDG PET showed not-
localizing hypometabolism in all 6 cases. In the remaining case
(patient 34), 18F-FDG PET showed a hypometabolic right temporal
lobe area that matched video-EEG– and SISCOM-positive findings
when MR imaging showed a discordant left temporal cavernous mal-
formation. Because the unclear nature of the neuroimaging results,
this patient was not considered for surgery.
The difference between the proportion of SISCOM and PET
localizing study was not significant (P 5 0.3). SISCOM and 18F-
FDG PET showed coinciding localizing-study results in 26 of 54
(48%) patients, classified as moderate concordance (k statistic of
concordance, 0.42).
All imaging results are shown in Table 1, and localizing-study
concordance of results among MR imaging, SISCOM, and 18F-
FDG PET is shown in Figure 3.
Surgical Results and Follow-up
On the basis of the decision of the epilepsy unit, 18 of 54 (33%)
patients underwent resective surgical treatment. Four of those re-
sections needed the use of iEEG to confirm the location and extent
of EZ for resection. Of all 18 resected brain tissues analyzed,
histopathologic examination revealed 14 cases of focal cortical
FIGURE 1. MR imaging, SISCOM, and 18F-FDG PET rate of localizing
study.
FIGURE 2. SISCOM and 18F-FDG PET in MR imaging normal, not-
localizing, and discordant cases.
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dysplasia, 1 case of low-grade glial tumor associated with cortical
dysplasia, 1 case of chronic herpes encephalitis, 1 case of a low-
grade astrocytoma, and 1 case of cortical tubers.
Up to the end of the study, 12-mo postoperative seizure
outcome evaluation was performed for 14 patients. For the
remaining 4 cases, only 6-mo postoperative evaluation was
possible. Twelve of 18 patients (67%) had favorable Engel
outcomes (class I and II) and 6 of 18 unfavorable Engel outcomes
(class III and IV). Vagus nerve stimulation was used in 5 of 54
patients, all of whom presented an unfavorable Engel outcome.
Unfavorable clinical outcome was attributed to incomplete epileptic
zone resection in 5 interventions: 3 cases of affected margins were
found after histopathologic analysis, and complete resection was
not achieved because of carotid artery involvement in one patient
with a right temporal low-grade astrocytoma and eloquent cortex
area involvement in another patient. The remaining case was a
patient with multiple cortical tubers in whom a right parietal cortical
tuber was identified as the EZ and was surgically removed. But
shortly after, epileptic seizures restarted because of new epilep-
togenic activity from a previously silent cortical tuber.
Of the group of 18 patients who underwent resective surgery,
MR imaging successfully localized PEZ in 13 of 18 cases (72%),
whereas both SISCOM and 18F-FDG PET independently showed
15 of 18 cases (83%) each. If we combine SISCOM and 18F-FDG
PET results, nuclear medicine imaging techniques successfully iden-
tified PEZ in all 18 of 18 patients (100%).
Data relating to the abnormal-finding brain location of each test,
use of iEEG, histopathologic study, and surgical outcome are listed
in Table 2. A sample case can be seen in Figure 4.
DISCUSSION
A careful assessment of drug-resistant epileptic pediatric pop-
ulation for surgical candidacy is often challenging and, although
multimodal neuroimaging techniques can play a key role, to date
there are no evidence-based guidelines for the EZ identification
process. Our work aimed to bring additional information on the role
that SISCOM and 18F-FDG PET could play in this pathology.
In this presurgical neuroimaging study, we found that together
SISCOM or 18F-FDG PET findings matched the brain location of
PEZ in 76% (41/54) of cases, with a significantly higher propor-
tion of localizing-study results for SISCOM (67% [36/54]) and
18F-FDG PET (57% [31/54]) than for MR imaging (39% [21/54]).
Localizing-study ratios in our group of patients are lower than
the results of other similar studies in children (8,16,19) in which
rates for localizing epileptogenic lesions ranged from 62% to 88%
for MR imaging, 76% to 89% for SISCOM, and 67% to 83% for
18F-FDG PET. But all 3 studies consider only a population of
surgically intervened pediatric patients; consequently, all complex
nonsurgical cases were consciously excluded from the study from
the outset. Although this may provide the most reliable gold stan-
dard, it could lead to an overestimating bias in neuroimaging
sensitivity rates. If within our studied population we consider only
the group of patients who had undergone surgery (18 patients),
localizing-study rates would rise to 72% for MR imaging and 83%
for SISCOM and 18F-FDG PET. All our surgically intervened pa-
tients had a SISCOM or 18F-FDG PET study classified as local-
izing study (100%).
The SISCOM proportion of localizing study was significantly
superior (P 5 0.004) to an unsubstracted ictal SPECT study (50%
vs. 67% of localizing study). The use of SISCOM via dedicated
software offers improved sensitivity by avoiding possible errors
related to the visual analysis of ictal SPECT alone. In the light of
our results and a large body of other concordant published studies
(8,16,17,20,21), we highly encourage the regular use of SISCOM in
the SPECT evaluation of pediatric drug-resistant epileptic patients.
Of the cases for which MR imaging showed a not-localizing
study, SISCOM findings matched the PEZ in 83% (5/6) of pa-
tients. Therefore, SISCOM proved particularly useful in the assess-
ment of those patients with abnormal MR imaging findings that
did not fully explain the presence of epileptic seizures such as
malacic changes related to ischemic or traumatic lesions, multiple
tubers, hippocampus sclerosis or hemispheric atrophy, or even the
reevaluation of an already surgically intervened brain area. In such
cases, 18F-FDG PET studies did not provide helpful information
TABLE 1
Imaging Results of All 54 Patients
Neuroimaging technique Normal Localizing study Lateralizing study Not-localizing study Discordant study
MR imaging 26 21 0 6 1
Interictal SPECT 28 17 4 4 1
Ictal SPECT 19 27 4 2 2
SISCOM 13 36 2 0 3
PET 13 31 2 6 2
FIGURE 3. Number of patients with localizing-study results by MR
imaging, SISCOM, and 18F-FDG PET and their concordance.
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TABLE 2
Neuroimaging Findings, Histopathologic Results, and Surgical Outcome of All Patients
Patient no./sex Age (y) PEZ MRI SISCOM PET Histopathology Engel
1/F 11 F/R F/R F/R F/R i-EEG – MCD I
2/F 4 Multifocal Normal Normal Normal
3/F 3 T/R T/R T/R T/R MCD I
4/M 9 F/L F/L F/L F/L MCD IV
5/M 1 T-O/R T-O/R T-O/R T-O/R MCD II
6/M 10 P/L Not-loc Normal Not-loc
7/F 22 F/L F/L F/L F/L
8/M 12 P/R Not-loc P/R Not-loc
9/M 15 P/R Normal P/R P/R
10/F 12 F/L F/L Normal Normal
11/M 5 F/R Normal Lat/R F/R VNS III
12/M 18 No PEZ Normal Normal Normal
13/M 4 P/R Not-loc P/R Not-loc Cortical tuber IV
14/M 9 F/R Not-loc F/R Not-loc Cronic herpetic encephalitis I
15/F 10 F/L Normal Normal F/L MCD III
16/F 9 F/R F/R F/R F/R MCD I
17/F 19 F/R Normal Normal T/L
18/M 4 F/L Normal T/R F/L MCD II
19/F 10 F/R F/R F/R F/R i-EEG – MCD II
20/M 8 T/R Normal T/R T/R
21/M 5 T/L Normal Normal T/L VNS IV
22/F 9 T/R T/R T/R T/R Low-grade astrocytoma IV
23/M 5 P/L Normal Normal Normal VNS IV
24/F 11 F/L Normal F/L F/L
25/M 6 O/R Normal O/R Normal
26/F 20 P/R Normal T/L Normal VNS IV
27/F 16 F/L Normal F/L Normal
28/F 12 T/L T/L T/L T/L
29/M 8 Lat/L Normal T-P/L T-P/L
30/M 4 F/R F/R F/R Normal MCD I
31/M 11 F-T/L F-T/L F-T/L Lat/L
32/F 12 P-T/R Normal Normal Normal
33/F 4 F/L F/L F/L F/L MCD IV*
34/F 1 T/R T/L T/R T/R
35/F 1 P-O/R P-O/R P-O/R P-O/R MCD II*
36/M 16 F/R Normal F/R F/R MCD IV
37/M 3 T/L T/L Normal T/L
Low-grade glial
tumor 1 cortical dysplasia
II
38/M 15 Lat/R Normal T/L T/L VNS IV
39/M 9 P/L P/L P/L P/L MCD I*
40/F 6 T/R T/R T/R T/R MCD I*
41/F 3 P-O/R Normal Normal Normal
42/M 6 P-O/R Normal P-O/R P-O/R
43/F 5 Lat/R Normal Lat/R Normal
44/M 1 T-P-O/R T-P-O/R Normal Normal
45/M 13 O-R Normal T-O/R O/R
46/M 12 O-R O/R O/R O/R
47/M 4 Lat/R Normal Normal F-P-T/R
48/F 11 Lat/L Not-loc P-O/L Not-loc
49/F 15 P-R P-T/R P/R P/R
50/F 1 T-R Normal T/R T/R
51/F 6 F-P-R F/R F/R F-P/R
52/M 1 T-L Not-loc T/L Not-loc
53/M 9 F-L Normal F/L F/L
54/M 18 F-R Normal F/R Normal
*Engel evaluation at 6 mo.
F 5 frontal; R 5 right; MCD 5malformation of cortical development; T 5 temporal; L 5 left; O 5 occipital; P 5 parietal; Not-loc 5 not-
localizing study; VNS 5 vagus nerve stimulation; Lat 5 lateralizing study.
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because they show only a hypometabolic area associated with the
MR imaging–spotted lesion. Within this clinical context, a positive
SISCOM finding concordant to PEZ can allow the option of sur-
gical treatment to be considered.
Even though no significant difference was found between SISCOM
and 18F-FDG PET localizing-study proportions, the k statistic
showed only a moderate rate of concordance. This rate would
suggest that the information provided by SISCOM and 18F-FDG
PET is not identical, making their contribution complementary.
We agree with the explanation put forward by Carren˜o and Lüders
(22) that SISCOM’s capacity to demonstrate cerebral blood flow
changes in the ictal state makes it a more suitable technique for
defining the seizure-onset zone, whereas 18F-FDG PET highlights
the functional deficit zone.
If we consider only nonlesional MR imaging cases (26/54 [48%]
of normal studies), SISCOM and 18F-FDG PET showed equal sen-
sitivity (13 [26%–50%]). As previously reported by our group and
other authors (14,17,23), 18F-FDG PET contribution is especially
valuable in nonlesional MR imaging situations. In these particular
cases, the information provided by SISCOM and 18F-FDG PET
can also be useful for guiding iEEG placement, minimizing the
need for invasive studies, and reducing the craniotomy size of
iEEG and the number of electrodes used (11,17).
Multimodal neuroimaging assessment in all 18 surgically in-
tervened patients was deemed successful because their epileptic
symptomatology was justifiable from histopathologic findings and
also because 12 patients presented a favorable Engel outcome. It
has already been shown that an incomplete resection of cortical
dysplasia is the main predictor of poor postsurgical outcome (24).
Of the 6 cases in which Engel outcome was unfavorable, 5 were
due to incomplete resection and there was 1 case of new epilep-
togenic activity coming from a previously silent cortical tuber.
Although the number of patients undergoing resective surgery
in this study is small, a favorable Engel outcome score is more
likely in those cases when all techniques (video-EEG, MR imaging,
SISCOM, and 18F-FDG PET) exhibit concordant localizing-study
results (8/10 [80%]).
This study holds some limitations; the use of a 3-T MR imaging
unit could have improved MR imaging sensitivity. Moreover, our
patient selection criteria may have led to an underestimation of
MR imaging sensitivity, because those cases in which MR imag-
ing was the only imaging study were not included. However, the
use of MR imaging has never been questioned because not only does
it establish the brain’s anatomic structures for surgical planning,
but also an MR imaging–identified lesion warrants surgical candi-
dacy and predicts a favorable surgical outcome (25–28). The stan-
dard for EZ localization (PEZ) was defined as a result of video-
EEG, clinical, and neuropsychologic data. Therefore, we agree
that there is not enough evidence to consider PEZ as definitive
and in some cases PEZ and EZ do not match. Nevertheless, the EZ
is a theoretic concept that can be confirmed only after achieving
postsurgical seizure freedom (3), hence, we consider PEZ as the
strongest criterion available in the noninvasive presurgical evalu-
ation of epileptic patients. This notion is supported because all
intervened patients demonstrated histopathologic findings that jus-
tified the presence of epileptic symptomatology.
Consistent with the current literature in this field, our results
suggest that nuclear medicine functional neuroimaging techniques
can actively improve the decision-taking process in complex cases
of pediatric epilepsy. Future work should focus on the elaboration
of clinical guidelines that will contribute to a better use of multi-
modal neuroimaging procedures and the consequent optimization
of evaluation for surgical candidacy.
It has been shown that long-term uncontrolled seizures can lead
to progressive cognitive deterioration and brain atrophy (29,30)
and that the longer the duration of epilepsy, the less likelihood of
achieving a favorable long-term surgical outcome (31,32). Hence,
any delay in surgical treatment should be reduced to a minimum.
The use of radionuclide imaging is particularly useful in the pe-
diatric population because of the complex nature of most cases
and the limitations of the MR imaging (5,7,33–35). We believe
that a multimodal neuroimaging approach should always be avail-
able in the assessment of pediatric drug-resistant epileptic patients.
CONCLUSION
SISCOM or 18F-FDG PET assessment provided important com-
plementary presurgical information that was concordant to the
PEZ in three fourths of our sample. SISCOM was particularly
useful in those cases in which MR imaging findings were abnor-
mal but no epileptogenic lesion was identified. Even though the
role of radionuclide imaging in adult epilepsy is mainly comple-
mentary, we believe that an accurate evaluation of drug-resistant
epileptic pediatric patients should always consider SISCOM or
18F-FDG PET evaluation. These techniques are useful and reliable
tools that can extend the possibility of surgical treatment to pa-
tients who may have been considered untreatable with surgery
without a nuclear medicine approach.
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